BRIEF-Charles River Q4 Adjusted EPS USD 2.39 Vs. IBES Estimate USD 2.34
Charles River Laboratories International, Inc. +0.54% Post
Charles River Laboratories International, Inc. CRL | 179.31 179.31 | +0.54% 0.00% Post |
Feb 18 (Reuters) - Charles River Q4 EPS USD -5.62.
- Q4 revenue USD 994.2 million vs. IBES estimate USD 987 million
- Q4 adjusted net income USD 118.8 million vs. IBES estimate USD 116.3 million
